ASMANEX HFA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the ASMANEX HFA drug offered from Merck Sharp & Dohme Corp.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | MOMETASONE FUROATE |
SUBSTANCE NAME: | MOMETASONE FUROATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | AEROSOL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-04-25 |
END MARKETING DATE: | 0000-00-00 |
ASMANEX HFA HUMAN PRESCRIPTION DRUG Details:
Item Description | ASMANEX HFA from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(ug/1) |
START MARKETING DATE: | 2014-04-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0085-4333_be997610-195c-4745-af7e-4627b0893235 |
PRODUCT NDC: | 0085-4333 |
APPLICATION NUMBER: | NDA205641 |
Other MOMETASONE FUROATE Pharmaceutical Manufacturers / Labelers: